Literature DB >> 27957088

Who Needs Pharmacologic Therapy?

Christopher P Porterfield1, Rohit Malhotra1.   

Abstract

Treatment of atrial fibrillation has evolved significantly in the last ten years, with ablation becoming a far more common form of treatment for this most common type of arrhythmias. However, while ablation has become more common, certain populations derive continued benefit from the use of pharmacologic therapy for treatment. We review the use of pharmacologic therapy and novel considerations for treatment of atrial fibrillation.

Entities:  

Keywords:  Atrial Fibrillation; Pharmacologic Therapy; Stroke Prevention

Year:  2014        PMID: 27957088      PMCID: PMC5135157          DOI: 10.4022/jafib.1084

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  23 in total

Review 1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

2.  Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study.

Authors:  Sanjay Dixit; Francis E Marchlinski; David Lin; David J Callans; Rupa Bala; Michael P Riley; Fermin C Garcia; Mathew D Hutchinson; Sarah J Ratcliffe; Joshua M Cooper; Ralph J Verdino; Vickas V Patel; Erica S Zado; Nancy R Cash; Tony Killian; Todd T Tomson; Edward P Gerstenfeld
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-12-02

3.  Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

Authors:  Jonas Bjerring Olesen; Laurent Fauchier; Deirdre A Lane; Sophie Taillandier; Gregory Y H Lip
Journal:  Chest       Date:  2011-06-16       Impact factor: 9.410

4.  Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.

Authors:  F Bellandi; I Simonetti; M Leoncini; F Frascarelli; T Giovannini; M Maioli; R P Dabizzi
Journal:  Am J Cardiol       Date:  2001-09-15       Impact factor: 2.778

5.  Amiodarone versus sotalol for atrial fibrillation.

Authors:  Bramah N Singh; Steven N Singh; Domenic J Reda; X Charlene Tang; Becky Lopez; Crystal L Harris; Ross D Fletcher; Satish C Sharma; J Edwin Atwood; Alan K Jacobson; H Daniel Lewis; Dennis W Raisch; Michael D Ezekowitz
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

Review 6.  Quality of life in patients with atrial fibrillation: a systematic review.

Authors:  Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

7.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

8.  Increased mortality after dronedarone therapy for severe heart failure.

Authors:  Lars Køber; Christian Torp-Pedersen; John J V McMurray; Ole Gøtzsche; Samuel Lévy; Harry Crijns; Jan Amlie; Jan Carlsen
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

9.  The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

Authors:  G N Kay; K A Ellenbogen; M Giudici; M M Redfield; L S Jenkins; M Mianulli; B Wilkoff
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.